Genevac Ltd. acquired by Riverlake Partners, LLC

16-Apr-2007

Riverlake Partners, LLC, a US-based private equity firm, announced the acquisition of Genevac Ltd from Thermo Fisher Scientific Inc. Neither the structure terms nor the value of the transaction were disclosed. MVC Capital participated in the financing, in conjunction with Riverlake.

Riverlake will merge Genevac into its platform investment, SP Industries, Inc. (SP) to create a dynamic global equipment company. Other SP brands include HotPack, VirTis and FTS, which was acquired in October 2006. Together, SP develops, manufactures and markets a line of laboratory equipment sold worldwide.

Charles L. Grant, a Riverlake partner and chief executive officer of SP, will lead Genevac's operations during the consolidation process and beyond.

Other news from the department business & finance

These products might interest you

tritec® Chromatographic refrigerators

tritec® Chromatographic refrigerators by tritec für Labortechnik und Umweltsimulation

Energy-efficient chromatography refrigerators for precise temperature control

Safe storage of your HPLC systems at -5 °C to 20 °C with modern touchscreen display

chromatography refrigerators
SmartCheck

SmartCheck by Mettler-Toledo

Check Pipette Dosing Accuracy - Lightning Fast in Under a Minute

Detect dosing errors before it gets expensive

pipette calibration devices
BIOS ANALYTIQUE - Soluciones de Renting y Leasing para laboratorios

BIOS ANALYTIQUE - Soluciones de Renting y Leasing para laboratorios by Bios Analytique

Specialists in the rental and leasing of scientific equipment for laboratories throughout Europe

Whether you have an unexpected requirement or limited budget, we have the perfect solution for you

lab equipment
Starlab Minizentrifuge

Starlab Minizentrifuge by STARLAB

The Starlab Minicentrifuge - ahead of the curve

This compact unit delivers quiet, intuitive and smooth operation along with a modern design

mini centrifuges
KNAUER IJM NanoScaler

KNAUER IJM NanoScaler by KNAUER

Efficient formulation of lipid nanoparticles for RNA-based therapies

Optimise drug encapsulation from 1 ml to hundreds of millilitres with minimal drug input

formulation systems
Loading...

Most read news

More news from our other portals

So close that even
molecules turn red...